PUBLICATION

Dr. Zehra Manzoor

 
2023 Haneef K, Salim A, Hashim Z, Ilyas A, Syed B, Ahmed A, Zarina S (2023) Chemical Hypoxic Preconditioning Improves Survival and Proliferation of Mesenchymal Stem Cells. Appl Biochem Biotechnol. https://doi.org/10.1007/s12010-023-04743-z.
2023 Tanveer F, Ilyas A, Syed B, Hashim Z, Ahmed A, Zarina S (2023) Differential Protein Expression in Response to Varlitinib Treatment in Oral Cancer Cell Line: an In Vitro Therapeutic Approach. Appl Biochem Biotechnol. https://doi.org/10.1007/s12010-023-04642-3.
2023 Jaffari SAZ, Abid T, Zohaib M, Ghulam Haider, Hashim Z. Genetic Predisposition of PON1 L55M (T172A) and Oxidative Stress in Breast Carcinogenesis among Pakistani Population. Pak J. of Zool. 2023. doi: https://dx.doi.org/10.17582/journal.pjz/20221130081107.
2023 Kafeel S, Bizenjo N, Shivji SS, Keran A, Hashim Z, Nawab SN. DNA Repair Enzyme XRCC4 30 bp Indel Intron 3 Locus Significant Association with Predisposition of Cataract in Senility. Appl Biochem Biotechnol. 2023. doi: 10.1007/s12010-023-04533-7.
2023 Syed N, Ilyas A, Syed B, Ahmed A, Zarina S, Hashim Z. Novel Synergistic Combination of Pamidronate and Temozolomide for Breast Cancer Therapeutics. Current Cancer Drug Targets. 2023; 23:222-234.
2022 Abid, T., Jaffari, S. A. Z., Zohaib, M., Jamil, M., Afzal, S., & Hashim, Z. (2022). Oxidative stress and PON1 (T172A/L55M) polymorphism: potential risk factors for Osteoarthritis. Journal of the Pakistan Medical Association. https://doi.org/10.47391/JPMA.3658
2022 Kafeel, S., Hashim, Z., Fawwad, A., & Nawab, S. N. (2022). Association of SOD1 Gene Promotor 50 Bp Indel Polymorphism with Susceptibility of Type 2 Diabetes Mellitus. Diabetes Obes Int J, 7(3), 000259. https://doi.org/10.23880/doij-16000259
2022 Kafeel, S., Hashim, Z., Fawwad, A., & Nawab, S. N. (2022). Predisposition of SOD1, GPX1, CAT genetic variants and their haplotypes in cataractogenesis of type 2 diabetes mellitus in Pakistan. Acta Diabetologica59(5), 623-632. https://doi.org/10.1007/s00592-021-01832-5
2022 Fazal, Y., Zohaib, M., Syed, B., Ansari, S. H., Hashim, Z., Ahmed, A., & Zarina, S. (2022). Prenatal diagnosis of maternal serum from mothers carrying β‐thalassemic fetus. Pediatrics International64(1), e14999.  https://doi.org/10.1111/ped.14999
2021 Mohsin, A., Haneef, K., Ilyas, A., Zarina, S., & Hashim, Z. (2021). Oxidative Stress Induced Cell Cycle Arrest: Potential Role of PRX-2 and GSTP-1 as Therapeutic Targets in Hepatocellular Carcinoma. Protein and Peptide Letters28(12), 1323-1329. https://doi.org/10.2174/0929866528666211105105953
2021 Usman, M., Ilyas, A., Syed, B., Hashim, Z., Ahmed, A., & Zarina, S. (2021). Serum HSP90-alpha and oral squamous cell carcinoma: a prospective biomarker. Protein and Peptide Letters28(10), 1157-1163. https://doi.org/10.2174/0929866528666210616112539
2020 Hashim, Z., Ilyas, A., & Zarina, S. (2020). Therapeutic effect of hydrogen peroxide via altered expression of glutathione S-transferase and peroxiredoxin-2 in hepatocellular carcinoma. Hepatobiliary & Pancreatic Diseases International19(3), 258-265. https://doi.org/10.1016/j.hbpd.2020.03.006
2020 Syed, N., Ilyas, A., Idrees, F., Zarina, S., & Hashim, Z. (2020). Inhibition of USP2 Induces apoptosis through down regulation of fatty acid synthase and Cyclin D1 in triple negative breast cancer. Current Proteomics17(5), 425-432. https://doi.org/10.2174/1570164617666191008093522
2020 Usman, M., Ilyas, A., Hashim, Z., & Zarina, S. (2020). Identification of GIMAP7 and Rabl3 as putative biomarkers for oral squamous cell carcinoma through comparative proteomic approach. Pathology & Oncology Research26(3), 1817-1822. https://doi.org/10.1007/s12253-019-00775-1
2020 Malik, U. U., Siddiqui, I. A., Ilyas, A., Hashim, Z., Staunton, L., Kwasnik, A., … & Zarina, S. (2020). Identification of differentially expressed proteins from smokeless tobacco addicted patients suffering from Oral squamous cell carcinoma. Pathology & Oncology Research26(3), 1489-1497. https://doi.org/10.1007/s12253-019-00724-y
2021 Fazal, Y., Zohaib, M., Hashim, Z., Ansari, S. H., & Zarina, S. (2021). Antioxidant Activity and Oxidative Stress Status in Maternal Serum of β-thalassemic Mothers Carrying β-thalassemic Major and Normal Fetuses. Fetal and Pediatric Pathology40(6), 563-570. https://doi.org/10.1080/15513815.2020.1725940
2019 Syed, N., Ilyas, A., Zarina, S., & Hashim, Z. (2019). Assessment of Anticancer Effect of Alendronate in Breast Cancer: An In vitro Study. J. Biotech. Biomed. Sci, 2(2), 1-7. https://doi.org/10.14302/issn.2576-6694.jbbs-19-2953
2018 Ilyas, A., Hashim, Z., Channa, I. S., & Zarina, S. (2018). Alendronate and FTI-277 combination as a possible therapeutic approach for hepatocellular carcinoma: An in vitro study. Hepatobiliary & Pancreatic Diseases International17(3), 241-250. https://doi.org/10.1016/j.hbpd.2018.03.013
2016 Atta, A., Ilyas, A., Hashim, Z., & Zarina, S. (2016). Structure Function Relationship of Lactate Dehydrogenase/[epsilon]-Crystallin from Lenses of Indian Spiny-Tailed Lizard (Uromastyx hardwickii). Pakistan Journal of Zoology48(4), 1147-1153.
2016 Zohaib, M., Ansari, S. H., Hashim, Z., Shamsi, T. S., & Zarina, S. (2016). Serum Paraoxonase Activity and Malondialdehyde Serum Concentrations Remain Unaffected in Response to Hydroxyurea Therapy in β‐Thalassemia Patients. The Journal of Clinical Pharmacology56(7), 869-874. https://doi.org/10.1002/jcph.675
2016 Atta, A., Hashim, Z., & Zarina, S. (2016). Lens proteomics: exploring adaptive conflict in Uromastyx hardwickii lens proteins. JAPS: Journal of Animal & Plant Sciences26(1), 261-268.
2015 Ilyas, A., Hashim, Z., & Zarina, S. (2015). Effects of 5′-azacytidine and alendronate on a hepatocellular carcinoma cell line: a proteomics perspective. Molecular and Cellular Biochemistry405(1), 53-61. https://doi.org/10.1007/s11010-015-2395-1
2014 Atta, A., Ilyas, A., Hashim, Z., Ahmed, A., & Zarina, S. (2014). Lactate dehydrogenase like crystallin: A potentially protective shield for Indian spiny-tailed lizard (Uromastyx hardwickii) lens against environmental Stress?. The protein journal33(2), 128-134. https://doi.org/10.1007/s10930-014-9543-4
2014 Ilyas, A., Hashim, Z., Naeem, N., Haneef, K., & Zarina, S. (2014). The effect of alendronate on proteome of hepatocellular carcinoma cell lines. International Journal of proteomics2014. https://doi.org/10.1155/2014/532953
2014 Malik, U. U., Siddiqui, I. A., Hashim, Z., & Zarina, S. (2014). Measurement of serum paraoxonase activity and MDA concentrations in patients suffering with oral squamous cell carcinoma. Clinica Chimica Acta, 430, 38-42. https://doi.org/10.1016/j.cca.2013.12.033
2012 Hashim, Z., & Zarina, S. (2012). Osmotic stress induced oxidative damage: possible mechanism of cataract formation in diabetes. Journal of diabetes and its complications26(4), 275-279. https://doi.org/10.1016/j.jdiacomp.2012.04.005
2011 Hashim, Z., & Zarina, S. (2011). Advanced glycation end products in diabetic and non-diabetic human subjects suffering from cataract. Age33(3), 377-384. https://doi.org/10.1007/s11357-010-9177-1
2009 Hashim, Z., Ilyas, A., Saleem, A., Salim, A., & Zarina, S. (2009). Expression and activity of paraoxonase 1 in human cataractous lens tissue. Free Radical Biology and Medicine46(8), 1089-1095. https://doi.org/10.1016/j.freeradbiomed.2009.01.012
2007 Hashim, Z., & Zarina, S. (2007). Assessment of paraoxonase activity and lipid peroxidation levels in diabetic and senile subjects suffering from cataract. Clinical biochemistry40(9-10), 705-709. https://doi.org/10.1016/j.clinbiochem.2007.03.015
2006 Hashim, Z., & Zarina, S. (2006). Antioxidant markers in human senile and diabetic cataractous lenses. J Coll Physicians Surg Pak16(10), 637-640.